Transamerica Financial Advisors LLC Purchases Shares of 3,652 Cigna Group $CI

Key Points

• Transamerica Financial Advisors purchased 3,652 Cigna shares worth approximately $1.01 million during the second quarter. Institutional investors collectively own 86.99% of Cigna’s outstanding stock.
• Cigna reported quarterly earnings of $7.78 per share, beating estimates of $7.60, while revenue rose 6.7% year over year to $70.04 billion. The company maintained fiscal 2026 earnings guidance of approximately $30.45 per share.
• Cigna declared a quarterly dividend of $1.56 per share, equivalent to an annualized $6.24 payout and a 2.2% yield. Analysts maintain a consensus “Moderate Buy” rating with an average price target of $339.45, despite recent insider selling.

Transamerica Financial Advisors LLC purchased a new stake in shares of Cigna Group (NYSE:CI - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 3,652 shares of the health services provider's stock, valued at approximately $1,007,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of CI. Wilkerson Advisory Group LLC bought a new stake in Cigna Group in the fourth quarter worth about $25,000. Osbon Capital Management LLC acquired a new stake in Cigna Group in the 2nd quarter valued at about $26,000. Kemnay Advisory Services Inc. bought a new position in shares of Cigna Group during the 4th quarter valued at about $29,000. Prosperity Bancshares Inc acquired a new position in shares of Cigna Group in the 4th quarter worth approximately $29,000. Finally, Johnson Financial Group Inc. acquired a new position in shares of Cigna Group in the 2nd quarter worth approximately $29,000. Institutional investors own 86.99% of the company's stock.

Insider Activity

In related news, insider Nicole S. Jones sold 19,436 shares of the firm's stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business's stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 23,012 shares of company stock worth $6,386,550. Company insiders own 0.60% of the company's stock.

Cigna Group Price Performance

CI opened at $281.01 on Thursday. The stock has a fifty day moving average of $283.58 and a 200-day moving average of $281.51. The firm has a market capitalization of $74.25 billion, a P/E ratio of 11.63, a PEG ratio of 0.96 and a beta of 0.29. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Equities analysts forecast that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group's dividend payout ratio (DPR) is presently 25.82%.

Analyst Ratings Changes

CI has been the subject of several recent research reports. Weiss Ratings reissued a "hold (c)" rating on shares of Cigna Group in a research note on Monday, June 1st. Barclays lifted their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a research report on Friday, July 31st. The Goldman Sachs Group upped their price target on Cigna Group from $335.00 to $340.00 and gave the company a "buy" rating in a report on Monday, May 4th. Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft lowered Cigna Group from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $303.00 to $302.00 in a research note on Wednesday, May 20th. Fifteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $339.45.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source